CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹3,230 Cr | ₹2,837 Cr | ₹2,474 Cr | ₹2,535 Cr | ₹2,508 Cr |
What is the latest Trade Payables ratio of CIPLA ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹3,230 Cr |
| Mar2025 | ₹2,837 Cr |
| Mar2024 | ₹2,474 Cr |
| Mar2023 | ₹2,535 Cr |
| Mar2022 | ₹2,508 Cr |
How is Trade Payables of CIPLA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,230 Cr | 13.83 | |
| Mar2025 | ₹2,837 Cr | 14.69 | |
| Mar2024 | ₹2,474 Cr | -2.39 | |
| Mar2023 | ₹2,535 Cr | 1.05 | |
| Mar2022 | ₹2,508 Cr | - | |
Compare Trade Payables of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹116,147.7 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
| MANKIND PHARMA | ₹98,499.5 Cr | -1.5% | -6.3% | -3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.9% |
1.6% |
-9.3% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses